We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
(+48%)
Cap. Flow
+$442M
Cap. Flow
% of AUM
18.15%
Top 10 Holdings %
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$55.3M |
| 2 |
Apple
AAPL
|
+$33.2M |
| 3 |
Amazon
AMZN
|
+$29.2M |
| 4 |
Microsoft
MSFT
|
+$26.4M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$342M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$93.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$86M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$51.5M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Healthcare | 9.57% |
| 3 | Financials | 8.79% |
| 4 | Industrials | 7.76% |
| 5 | Consumer Discretionary | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
2976
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $55K | ﹤0.01% |
983
-2,891
| -75% | -$124K |
|
2977
Gencor Industries
GENC
$268M
| $54K | ﹤0.01% |
4,280
+3,294
| +334% | +$38.1K |
|
2978
SPDR Gold Trust
GLD
$144B
| $54K | ﹤0.01% |
320
-480
| -60% | -$77.4K |
|
2979
International Money Express
IMXI
$341M
| $54K | ﹤0.01% |
4,376
+4,216
| +2,635% | +$42.9K |
|
2980
KALA BIO
KALA
$16.3M
| $54K | ﹤0.01% |
+2
| New | +$56.7K |
|
2981
Children's Place
PLCE
$55.1M
| $54K | ﹤0.01% |
1,421
-698
| -33% | -$23.7K |
|
2982
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.97B
| $54K | ﹤0.01% |
+3,122
| New | +$52.2K |
|
2983
Quanterix
QTRX
$121M
| $54K | ﹤0.01% |
+1,960
| New | +$49.5K |
|
2984
Suncor Energy
SU
$74.5B
| $54K | ﹤0.01% |
3,254
-25,643
| -89% | -$438K |
|
2985
BlackRock TCP Capital
TCPC
$329M
| $54K | ﹤0.01% |
5,926
+2,163
| +57% | +$18.6K |
|
2986
Viper Energy
VNOM
$15.3B
| $54K | ﹤0.01% |
+5,223
| New | +$50.1K |
|
2987
VSE Corp
VSEC
$6.7B
| $54K | ﹤0.01% |
+1,708
| New | +$38.9K |
|
2988
Cactus
WHD
$5.77B
| $54K | ﹤0.01% |
+2,631
| New | +$45.6K |
|
2989
Metallus
MTUS
$901M
| $54K | ﹤0.01% |
13,930
+10,311
| +285% | +$34.5K |
|
|
ALR
2990
DELISTED
AlerisLife Inc
ALR
| $54K | ﹤0.01% |
13,800
-7,525
| -35% | -$26.8K |
|
|
LORL
2991
DELISTED
Loral Space and Communications, Inc.
LORL
| $54K | ﹤0.01% |
2,750
-10,011
| -78% | -$187K |
|
|
CHL
2992
DELISTED
China Mobile Limited
CHL
| $54K | ﹤0.01% |
+1,607
| New | +$59.5K |
|
2993
Blue Bird Corp
BLBD
$2.03B
| $53K | ﹤0.01% |
+3,552
| New | +$44.6K |
|
2994
Digimarc Corp
DMRC
$173M
| $53K | ﹤0.01% |
+3,283
| New | +$52.7K |
|
2995
Fidus Investment
FDUS
$750M
| $53K | ﹤0.01% |
5,848
+2,046
| +54% | +$17.8K |
|
2996
Live Oak Bancshares
LOB
$1.97B
| $53K | ﹤0.01% |
3,644
-1,746
| -32% | -$23.7K |
|
2997
Midland States Bancorp
MSBI
$695M
| $53K | ﹤0.01% |
+3,572
| New | +$54.9K |
|
2998
PAVmed
PAVM
$32.9M
| $53K | ﹤0.01% |
+55
| New | +$55K |
|
2999
SiTime
SITM
$20.8B
| $53K | ﹤0.01% |
+1,118
| New | +$33.2K |
|
3000
Sanofi
SNY
$104B
| $53K | ﹤0.01% |
1,037
+1,020
| +6,000% | +$49.6K |
|
Similar funds
CA
BHC
ICP
AP
BWA
JSW
SP
GCM
Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review
As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.
- Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
- Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
- Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
- Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
- Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
- Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
- Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.